A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac

被引：29
|
作者：
Mok, Chris Ka Pun [1 ,2 ]
Chen, Chunke [1 ,2 ]
Yiu, Karen [2 ]
Chan, Tat-On [2 ]
Lai, Kiu Cheung [2 ]
Ling, Kwun Cheung [2 ]
Sun, Yuanxin [1 ,2 ]
Hui, David S. [2 ]
Cheng, Samuel M. S. [3 ]
Peiris, Malik [3 ]
机构：
[1] Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Hong Kong, Peoples R China
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷 / 07期
基金：
中国国家自然科学基金; 新加坡国家研究基金会;
关键词：
D O I：
10.1164/rccm.202111-2655LE
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：844 / 847
页数：4
相关论文
共 50 条
  • [1] CoronaVac or BNT162b2 Vaccine as a Third Dose
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (03) : 360 - 361
  • [2] CoronaVac or BNT162b2 Vaccine as a Third Dose Reply
    Mok, Chris Ka Pun
    Hui, David S.
    Peiris, Malik
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (03) : 361 - 362
  • [3] SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen
    Keskin, Ali Umit
    Bolukcu, Sibel
    Ciragil, Pinar
    Topkaya, Aynur Eren
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (01) : 39 - 41
  • [4] BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac
    Erol, Cigdem
    Kuloglu, Zeynep Ece
    Kayaaslan, Bircan
    Esken, Guelen
    Altunsoy, Adalet
    Barlas, Tayfun
    Cinar, Guele
    Hasanoglu, Imran
    Oruc, Ebru
    Incir, Said
    Azap, Alpay
    Korkmaz, Guelten
    Gokce, Dilara Turan
    Kirimker, Onur Elvan
    Yenigun, Ezgi Coskun
    Olcuecueoglu, Erkan
    Soy, Ebru Ayvazoglu
    Cetinkunar, Sueleyman
    Kurt Azap, Oezlem
    Can, Fuesun
    Haberal, Mehmet
    VIRUSES-BASEL, 2023, 15 (07):
  • [5] Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil
    Cerqueira-Silva, Thiago
    Katikireddi, Srinivasa Vittal
    Oliveira, Vinicius de Araujo
    Flores-Ortiz, Renzo
    Bertoldo Junior, Juracy
    Paixao, Enny S.
    Robertson, Chris
    Penna, Gerson O.
    Werneck, Guilherme L.
    Barreto, Mauritio L.
    Pearce, Neil
    Sheikh, Aziz
    Barral-Netto, Manoel
    Boaventura, Viviane S.
    NATURE MEDICINE, 2022, 28 (04) : 838 - +
  • [6] Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil
    Thiago Cerqueira-Silva
    Srinivasa Vittal Katikireddi
    Vinicius de Araujo Oliveira
    Renzo Flores-Ortiz
    Juracy Bertoldo Júnior
    Enny S. Paixão
    Chris Robertson
    Gerson O. Penna
    Guilherme L. Werneck
    Maurício L. Barreto
    Neil Pearce
    Aziz Sheikh
    Manoel Barral-Netto
    Viviane S. Boaventura
    Nature Medicine, 2022, 28 : 838 - 843
  • [7] Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey
    Sonmezer, Meliha Cagla
    Dizman, Gulcin Telli
    Erul, Enes
    Sahin, Taha Koray
    Saricaoglu, Tugba
    Alp, Alparslan
    Tanriover, Mine Durusu
    Uzun, Omrum
    Unal, Serhat
    Akova, Murat
    VACCINES, 2022, 10 (07)
  • [8] Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity
    Leung, Daniel
    Mu, Xiaofeng
    Duque, Jaime S. Rosa
    Cheng, Samuel M. S.
    Wang, Manni
    Zhang, Wenyue
    Zhang, Yanmei
    Tam, Issan Y. S.
    Lee, Toby S. S.
    Lam, Jennifer H. Y.
    Chan, Sau Man
    Cheang, Cheuk Hei
    Chung, Yuet
    Wong, Howard H. W.
    Lee, Amos M. T.
    Li, Wing Yan
    Chaothai, Sara
    Tsang, Leo C. H.
    Chua, Gilbert T.
    Cheong, Kai-Ning
    Au, Elaine Y. L.
    Kwok, Janette S. Y.
    Chan, Koon Wing
    Chong, Patrick C. Y.
    Lee, Pamela P. W.
    Ho, Marco H. K.
    Lee, Tsz Leung
    Tu, Wenwei
    Peiris, Malik
    Lau, Yu Lung
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] Acute diabetes complications not increased by CoronaVac or BNT162b2
    Reactions Weekly, 2022, 1927 (1) : 9 - 9
  • [10] Strength and durability of antibody responses to BNT162b2 and CoronaVac
    Cowling, Benjamin J.
    Wong, Irene O. L.
    Shiu, Eunice Y. C.
    Lai, Amber Y. T.
    Cheng, Samuel M. S.
    Chaothai, Sara
    Kwan, Kelvin K. H.
    Martin-Sanchez, Mario
    Poon, Leo L. M.
    Ip, Dennis K. M.
    Leung, Gabriel M.
    Leung, Nancy H. L.
    Peiris, J. S. Malik
    VACCINE, 2022, 40 (32) : 4312 - 4317
12345